139 related articles for article (PubMed ID: 10995007)
1. Relapse in childhood acute lymphoblastic leukemia is associated with a decrease of the Bax/Bcl-2 ratio and loss of spontaneous caspase-3 processing in vivo.
Prokop A; Wieder T; Sturm I; Essmann F; Seeger K; Wuchter C; Ludwig WD; Henze G; Dörken B; Daniel PT
Leukemia; 2000 Sep; 14(9):1606-13. PubMed ID: 10995007
[TBL] [Abstract][Full Text] [Related]
2. Mutant p53 protein, Bcl-2/Bax ratios and apoptosis in paediatric acute lymphoblastic leukaemia.
Srinivas G; Kusumakumary P; Nair MK; Panicker KR; Pillai MR
J Cancer Res Clin Oncol; 2000 Jan; 126(1):62-7. PubMed ID: 10641752
[TBL] [Abstract][Full Text] [Related]
3. Relationship between nitrogen mustard drug resistance in B-cell chronic lymphocytic leukemia (B-CLL) and protein expression of Bcl-2, Bax, Bcl-X and p53.
Christodoulopoulos G; Fotouhi N; Krajewski S; Reed JC; Alaoui-Jamali M; Panasci L
Cancer Lett; 1997 Dec; 121(1):59-67. PubMed ID: 9459175
[TBL] [Abstract][Full Text] [Related]
4. Bax-alpha promotes apoptosis induced by cancer chemotherapy and accelerates the activation of caspase 3-like cysteine proteases in p53 double mutant B lymphoma Namalwa cells.
Schmitt E; Steyaert A; Cimoli G; Bertrand R
Cell Death Differ; 1998 Jun; 5(6):506-16. PubMed ID: 10200502
[TBL] [Abstract][Full Text] [Related]
5. Diversity of the apoptotic response to chemotherapy in childhood leukemia.
Liu T; Raetz E; Moos PJ; Perkins SL; Bruggers CS; Smith F; Carroll WL
Leukemia; 2002 Feb; 16(2):223-32. PubMed ID: 11840289
[TBL] [Abstract][Full Text] [Related]
6. Caspase-dependent cytosolic release of cytochrome c and membrane translocation of Bax in p53-induced apoptosis.
Gao CF; Ren S; Zhang L; Nakajima T; Ichinose S; Hara T; Koike K; Tsuchida N
Exp Cell Res; 2001 Apr; 265(1):145-51. PubMed ID: 11281652
[TBL] [Abstract][Full Text] [Related]
7. Flavokawain B inhibits the growth of acute lymphoblastic leukemia cells via p53 and caspase-dependent mechanisms.
Tang YL; Huang LB; Tian Y; Wang LN; Zhang XL; Ke ZY; Deng WG; Luo XQ
Leuk Lymphoma; 2015; 56(8):2398-407. PubMed ID: 25641429
[TBL] [Abstract][Full Text] [Related]
8. Prognostic significance of p53 and Bcl-2 in acute lymphoblastic leukemia.
Sahu GR; Das BR
Oncol Rep; 2002; 9(6):1391-8. PubMed ID: 12375054
[TBL] [Abstract][Full Text] [Related]
9. Smac induces cytochrome c release and apoptosis independently from Bax/Bcl-x(L) in a strictly caspase-3-dependent manner in human carcinoma cells.
Hasenjäger A; Gillissen B; Müller A; Normand G; Hemmati PG; Schuler M; Dörken B; Daniel PT
Oncogene; 2004 Jun; 23(26):4523-35. PubMed ID: 15064710
[TBL] [Abstract][Full Text] [Related]
10. Increased BAX expression is associated with an increased risk of relapse in childhood acute lymphocytic leukemia.
Hogarth LA; Hall AG
Blood; 1999 Apr; 93(8):2671-8. PubMed ID: 10194447
[TBL] [Abstract][Full Text] [Related]
11. P53 mediates ceramide-induced apoptosis in SKN-SH cells.
Kim SS; Chae HS; Bach JH; Lee MW; Kim KY; Lee WB; Jung YM; Bonventre JV; Suh YH
Oncogene; 2002 Mar; 21(13):2020-8. PubMed ID: 11960374
[TBL] [Abstract][Full Text] [Related]
12. Prognostic value of p53 mutations, bax, and spontaneous apoptosis in maxillary sinus squamous cell carcinoma.
Bandoh N; Hayashi T; Kishibe K; Takahara M; Imada M; Nonaka S; Harabuchi Y
Cancer; 2002 Apr; 94(7):1968-80. PubMed ID: 11932899
[TBL] [Abstract][Full Text] [Related]
13. Elevated expression of the apoptotic regulator Mcl-1 at the time of leukemic relapse.
Kaufmann SH; Karp JE; Svingen PA; Krajewski S; Burke PJ; Gore SD; Reed JC
Blood; 1998 Feb; 91(3):991-1000. PubMed ID: 9446661
[TBL] [Abstract][Full Text] [Related]
14. Apoptotic and predictive factors by Bax, Caspases 3/9, Bcl-2, p53 and Ki-67 in prostate cancer after 12 Gy single-dose.
Pisani C; Ramella M; Boldorini R; Loi G; Billia M; Boccafoschi F; Volpe A; Krengli M
Sci Rep; 2020 Apr; 10(1):7050. PubMed ID: 32341393
[TBL] [Abstract][Full Text] [Related]
15. Relationship between Bax and Bcl-2 Protein Expression and Outcome of Induction Phase Chemotherapy in Pediatric Acute Lymphoblastic Leukemia.
Cahyadi A; Ugrasena IDG; Andarsini MR; Larasati MCS; Aryati A; Arumsari DK
Asian Pac J Cancer Prev; 2022 May; 23(5):1679-1685. PubMed ID: 35633553
[TBL] [Abstract][Full Text] [Related]
16. Expression of wild-type p53 and Bcl-2 family genes oscillates with recurrent remission and relapse in an unusual case of low-grade lymphoma.
Aizman I; Many A; Peller S; Ramot B; Kaufmann Y
Acta Haematol; 2000; 103(4):177-85. PubMed ID: 11014890
[TBL] [Abstract][Full Text] [Related]
17. P53, MDM-2, BAX and BCL-2 and drug resistance in chronic lymphocytic leukemia.
Johnston JB; Daeninck P; Verburg L; Lee K; Williams G; Israels LG; Mowat MR; Begleiter A
Leuk Lymphoma; 1997 Aug; 26(5-6):435-49. PubMed ID: 9389352
[TBL] [Abstract][Full Text] [Related]
18. Abnormalities of the P53, MDM2, BCL2 and BAX genes in acute leukemias.
Wojcik I; Szybka M; Golanska E; Rieske P; Blonski JZ; Robak T; Bartkowiak J
Neoplasma; 2005; 52(4):318-24. PubMed ID: 16059649
[TBL] [Abstract][Full Text] [Related]
19. Combretastatin-A4 prodrug induces mitotic catastrophe in chronic lymphocytic leukemia cell line independent of caspase activation and poly(ADP-ribose) polymerase cleavage.
Nabha SM; Mohammad RM; Dandashi MH; Coupaye-Gerard B; Aboukameel A; Pettit GR; Al-Katib AM
Clin Cancer Res; 2002 Aug; 8(8):2735-41. PubMed ID: 12171907
[TBL] [Abstract][Full Text] [Related]
20. Drug-induced apoptosis in chronic lymphocytic leukemia.
Stoetzer OJ; Pogrebniak A; Scholz M; Pelka-Fleischer R; Gullis E; Darsow M; Nüssler V; Wilmanns W
Leukemia; 1999 Nov; 13(11):1873-80. PubMed ID: 10557065
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
